04:44:01 EDT Tue 14 Apr 2026
Enter Symbol
or Name
USA
CA



Redwood AI Corp
Symbol AIRX
Shares Issued 34,304,753
Close 2026-04-13 C$ 7.01
Market Cap C$ 240,476,319
Recent Sedar+ Documents

Redwood appoints Shahrokhi as director; Stadnyk resigns

2026-04-13 20:40 ET - News Release

Mr. Louis Dron reports

REDWOOD AI ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

Redwood AI Corp. has appointed Sam Shahrokhi to its board of directors, effective immediately. Mr. Shahrokhi is an accomplished entrepreneur and business development executive with broad experience across the health, biotechnology and mining industries. Over the course of his career, he has held numerous leadership roles, and has been involved with a variety of successful private and public companies. Recognized for his strategic vision and ability to identify emerging opportunities, Mr. Shahrokhi has played an important role in helping businesses scale, strengthen their market position and create long-term shareholder value.

With a focus on complex and high-growth opportunities, Mr. Shahrokhi has supported the development and expansion of a diverse range of businesses. His experience in corporate development, strategic growth and value creation has supported companies through key stages of expansion and market development. Mr. Shahrokhi is the founder and president of One51 Financial Services, a Vancouver-based firm providing accounting, corporate and financial support services to public and private companies. Mr. Shahrokhi replaces Zachary Stadnyk, who has stepped down from the board. The company extends its gratitude to Mr. Stadnyk for his dedication and contributions during his tenure.

About Redwood AI Corp.

Redwood AI uses advanced artificial intelligence to accelerate chemistry research and development, with the aim of assisting in drug discovery and development, and furthering defence and safety solutions. The company combines expertise in chemistry, AI and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform enables faster, more efficient development of new therapies and chemistry-driven applications.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.